Skip to search.
 TSX Up 0.04% TSX Ventures Up 0.60%

Gilead Sciences Inc. (GILD)

-NasdaqGS
80.44 Down 0.06(0.07%) 10:57AM EDT - Nasdaq Real Time Price
Prev Close:80.50
Open:80.45
Bid:80.45 x 400
Ask:80.47 x 600
1y Target Est:105.65
Beta:0.985643
Earnings Date:Oct 25 - Oct 31 (Est.)
Day's Range:80.15 - 80.99
52wk Range:77.92 - 113.31
Volume:1,739,297
Avg Vol (3m):10,121,600
Market Cap:106.15B
P/E (ttm):7.06
EPS (ttm):11.39
Div & Yield:1.88 (2.32%)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
GILDDown 0.07%106.15B
GSKUp 0.25%106.97B
PFEUp 0.86%213.03B

Key Statistics

Forward P/E (1 yr):6.88
P/S (ttm):3.28
Ex-Dividend Date:14-Sep-16

Analysts

Annual EPS Est (Dec-16) :11.78
Quarterly EPS Est (Sep-16) :2.88
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):85.38

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Gilead Sciences, Inc., a research-based biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical needs in North America, South America, Europe, and the Asia-Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback